• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃克受体酪氨酸激酶的配体B61在肿瘤坏死因子-α诱导的血管生成中的作用。

Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.

作者信息

Pandey A, Shao H, Marks R M, Polverini P J, Dixit V M

机构信息

Department of Pathology, University of Michigan Medical School, Ann Arbor 48109, USA.

出版信息

Science. 1995 Apr 28;268(5210):567-9. doi: 10.1126/science.7536959.

DOI:10.1126/science.7536959
PMID:7536959
Abstract

B61, a cytokine-inducible endothelial gene product, is the ligand for the Eck receptor protein tyrosine kinase (RPTK). Expression of a B61-immunoglobulin chimera showed that B61 could act as an angiogenic factor in vivo and a chemoattractant for endothelial cells in vitro. The Eck RPTK was activated by tumor necrosis factor-alpha (TNF-alpha) through induction of B61, and an antibody to B61 attenuated angiogenesis induced by TNF-alpha but not by basic fibroblast growth factor. This finding suggests the existence of an autocrine or paracrine loop involving activation of the Eck RPTK by its inducible ligand B61 after an inflammatory stimulus, the net effect of which would be to promote angiogenesis, a hallmark of chronic inflammation.

摘要

B61是一种细胞因子诱导的内皮基因产物,是Eck受体蛋白酪氨酸激酶(RPTK)的配体。B61-免疫球蛋白嵌合体的表达表明,B61在体内可作为血管生成因子,在体外可作为内皮细胞的趋化因子。肿瘤坏死因子-α(TNF-α)通过诱导B61激活Eck RPTK,而抗B61抗体可减弱TNF-α诱导的血管生成,但对碱性成纤维细胞生长因子诱导的血管生成无影响。这一发现提示,在炎症刺激后,存在一个自分泌或旁分泌环路,涉及Eck RPTK被其诱导性配体B61激活,其净效应是促进血管生成,这是慢性炎症的一个标志。

相似文献

1
Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.埃克受体酪氨酸激酶的配体B61在肿瘤坏死因子-α诱导的血管生成中的作用。
Science. 1995 Apr 28;268(5210):567-9. doi: 10.1126/science.7536959.
2
B61 is a ligand for the ECK receptor protein-tyrosine kinase.
Nature. 1994 Apr 7;368(6471):558-60. doi: 10.1038/368558a0.
3
Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function.上皮细胞激酶 - B61:一种调节肠道上皮迁移和屏障功能的自分泌环。
Am J Physiol. 1997 Oct;273(4):G824-32. doi: 10.1152/ajpgi.1997.273.4.G824.
4
Characterization of B61, the ligand for the Eck receptor protein-tyrosine kinase.
J Biol Chem. 1995 Mar 10;270(10):5636-41. doi: 10.1074/jbc.270.10.5636.
5
Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
Cancer Res. 1995 Jun 15;55(12):2528-32.
6
Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity.
J Biol Chem. 1994 Dec 2;269(48):30154-7.
7
Molecular cloning and expression of rat and mouse B61 gene: implications on organogenesis.
Oncogene. 1995 Sep 7;11(5):879-83.
8
Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.EphA受体酪氨酸激酶激活的阻断抑制血管内皮生长因子诱导的血管生成。
Mol Cancer Res. 2002 Nov;1(1):2-11.
9
cDNA cloning and characterization of a ligand for the Cek5 receptor protein-tyrosine kinase.Cek5受体蛋白酪氨酸激酶配体的cDNA克隆与特性分析
J Biol Chem. 1994 Oct 28;269(43):26606-9.
10
EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.EphA2受体酪氨酸激酶通过磷酸肌醇3激酶介导的Rac1 GTP酶激活来调节内皮细胞迁移和血管组装。
J Cell Sci. 2004 Apr 15;117(Pt 10):2037-49. doi: 10.1242/jcs.01061. Epub 2004 Mar 30.

引用本文的文献

1
Differential association of EphA2 intracellular regions in biased signaling.EphA2细胞内区域在偏向性信号传导中的差异关联
J Biol Chem. 2025 Apr;301(4):108383. doi: 10.1016/j.jbc.2025.108383. Epub 2025 Mar 4.
2
in gastrointestinal cancer: Expression, regulation and clinical significance.在胃肠道癌中:表达、调控及临床意义。
World J Gastrointest Oncol. 2022 May 15;14(5):973-988. doi: 10.4251/wjgo.v14.i5.973.
3
Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening.
分子靶向癌症治疗的演变:耐药机制及CRISPR-Cas9筛选发现的新机遇
Front Oncol. 2022 Mar 17;12:755053. doi: 10.3389/fonc.2022.755053. eCollection 2022.
4
Ligands with different dimeric configurations potently activate the EphA2 receptor and reveal its potential for biased signaling.具有不同二聚体构型的配体可有效激活EphA2受体,并揭示其偏向性信号传导的潜力。
iScience. 2022 Feb 4;25(3):103870. doi: 10.1016/j.isci.2022.103870. eCollection 2022 Mar 18.
5
Role of endothelial cells in tumor microenvironment.内皮细胞在肿瘤微环境中的作用。
Clin Transl Med. 2021 Jun;11(6):e450. doi: 10.1002/ctm2.450.
6
The Role of Eph Receptors and Ephrins in Corneal Physiology and Diseases.Eph 受体及其配体在角膜生理和疾病中的作用。
Int J Mol Sci. 2021 Apr 27;22(9):4567. doi: 10.3390/ijms22094567.
7
EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice.EphrinA1-Fc 可减轻慢性非再灌注 WT 小鼠但不能减轻 EphA2-R-M 小鼠的心室重构和功能障碍。
Int J Mol Sci. 2020 Aug 13;21(16):5811. doi: 10.3390/ijms21165811.
8
EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria.EphA2 有助于大脑疟疾中血脑屏障的破坏。
PLoS Pathog. 2020 Jan 30;16(1):e1008261. doi: 10.1371/journal.ppat.1008261. eCollection 2020 Jan.
9
Use of Multifactorial Treatments to Address the Challenge of Translating Experimental Myocardial Infarct Reduction Strategies.采用多因素治疗应对实验性心肌梗死减少策略的转化挑战。
Int J Mol Sci. 2019 Mar 22;20(6):1449. doi: 10.3390/ijms20061449.
10
Micrornas at the Interface between Osteogenesis and Angiogenesis as Targets for Bone Regeneration.微小 RNA 在成骨与血管生成的相互作用及其在骨再生中的作用靶点
Cells. 2019 Feb 3;8(2):121. doi: 10.3390/cells8020121.